{"id":21709,"date":"2025-04-20T09:11:33","date_gmt":"2025-04-20T02:11:33","guid":{"rendered":"https:\/\/thaipropertynews.com\/feeds\/?p=21709"},"modified":"2025-04-20T09:11:33","modified_gmt":"2025-04-20T02:11:33","slug":"innovation-and-collaboration-advancing-chinas-blood-purification-industry","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=21709","title":{"rendered":"Innovation and Collaboration: Advancing China&#8217;s Blood Purification Industry"},"content":{"rendered":"<p><span class=\"legendSpanClass\">LIUYANG, <span class=\"xn-location\">China<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">April 19, 2025<\/span><\/span> \/PRNewswire\/ &#8212; On <span class=\"xn-chron\">April 19, 2025<\/span>, the Blood Purification Professional Committee (BPPC) of the China Medical Device Industry Association (CMDIA) gathered in Liuyang, <span class=\"xn-location\">Hunan<\/span>, for its annual conference, themed &#8220;Synergy and Endless Innovation.&#8221; This pivotal event united regulatory leaders, academic experts, and pioneering medical device companies to propel advancements in blood\u00a0purification technologies, integral to treating kidney disease, poisoning, multi-organ failure, and immune disorders.<\/p>\n<p>With over 120 million people suffering from chronic kidney disease, and over 1 million requiring dialysis, affordable and accessible treatment is urgent. Historically reliant on expensive imported technologies, <span class=\"xn-location\">China&#8217;s<\/span> shift towards domestic innovation marks a transformative era under BPPC&#8217;s leadership. \u00a0&#8220;Our mission is to connect cutting-edge technology with patient needs,&#8221; stated\u00a0Professor Wang Niansong, the committee&#8217;s chair and Chief of Nephrology at Shanghai Sixth People&#8217;s Hospital. The conference highlighted collaborative efforts across academia, industry, and regulators that are enhancing blood purification systems including advancements in blood purification technologies, smart monitoring systems, and integrated care platforms.<\/p>\n<p>Companies like <span class=\"xn-location\">Chongqing&#8217;s<\/span> SWS Medical are at the forefront of this movement, exemplifying innovation and significantly contributing to national standards. Tong Jin, Director of SWS Medical&#8217;s Technology Center, shared the company&#8217;s decade-long journey, highlighting breakthroughs in dialysis machines and high-end continuous renal replacement therapy (CRRT) equipment. &#8220;Our achievements, recognized through key national programs and patents, show that Chinese firms can lead in complex medical fields,&#8221; he said, reflecting the industry&#8217;s broader push toward self innovation and excellence.<\/p>\n<p>The conference explored innovations including precision medicine with targeted plasma purification and AI-optimized parameters, alongside breakthroughs like\u00a0ultra-pure dialysis via Central Concentrate Delivery System and IoT-enabled smart peritoneal dialysis management. Advances in\u00a0treatments for kidney diseases, including Immunoglobulin A nephropathy and emerging technologies like gene sequencing and stem cells, signal a shift toward proactive health management. These multidisciplinary and early intervention efforts have significant global potential.<\/p>\n<p>The conference centered on integrating\u00a0artificial intelligence to develop &#8220;Smart Hemodialysis&#8221; ecosystems, with\u00a0companies like SWS Medical leading this shift through\u00a0their &#8220;Device + System + Service&#8221; model that synergies medical devices, data analytics, and remote services to boost efficiency and expand accessibility, especially in underserved \u00a0areas. With domestic medical device registration reaching \u00a067.01% and over 90% of blood perfusion devices now localized, <span class=\"xn-location\">China&#8217;s<\/span> advancements\u00a0are\u00a0firmly supported by robust government initiatives and market-driven innovation, ensuring adherence to stringent clinical and regulatory standards.<\/p>\n<p>Chinese companies are now exporting affordable, high-quality solutions that challenge\u00a0Western-dominated markets while aligning with the &#8220;Healthy China 2030&#8221; strategy and the World Health Organization&#8217;s 2030 goals for chronic kidney disease. As <span class=\"xn-location\">China<\/span> approaches \u00a0the conclusion\u00a0of its 14th Five-Year Plan, this\u00a0conference signifies a pivotal moment, with the committee&#8217;s leadership and companies\u00a0like SWS Medical spearheading a transformation\u00a0toward intelligent, patient-centered, and globally competitive technologies.<\/p>\n<p>For patients, this\u00a0translates to\u00a0greater access to life-saving treatments, while for the global medical community, it underscores <span class=\"xn-location\">China&#8217;s<\/span> emergence as a leader in healthcare innovation. As Professor Wang eloquently stated, &#8220;The spark of innovation ignited here will transform lives far beyond <span class=\"xn-location\">China&#8217;s<\/span> borders.&#8221;<\/p>\n<p>\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p><span class=\"legendSpanClass\">LIUYANG, <span class=\"xn-location\">China<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">April 19, 2025<\/span><\/span> \/PRNewswire\/ &#8212; On <span class=\"xn-chron\">April 19, 2025<\/span>, the Blood Purification Professional Committee (BPPC) of the China Medical Device Industry Association (CMDIA) gathered in Liuyang, <span class=\"xn-location\">Hunan<\/span>, for its annual conference, themed &#8220;Synergy and Endless Innovation.&#8221; This pivotal event united regulatory leaders, academic experts, and pioneering medical device companies to propel advancements in blood\u00a0purification technologies, integral to treating kidney disease, poisoning, multi-organ failure, and immune disorders.<\/p>\n<p>With over 120 million people suffering from chronic kidney disease, and over 1 million requiring dialysis, affordable and accessible treatment is urgent. Historically reliant on expensive imported technologies, <span class=\"xn-location\">China&#8217;s<\/span> shift towards domestic innovation marks a transformative era under BPPC&#8217;s leadership. \u00a0&#8220;Our mission is to connect cutting-edge technology with patient needs,&#8221; stated\u00a0Professor Wang Niansong, the committee&#8217;s chair and Chief of Nephrology at Shanghai Sixth People&#8217;s Hospital. The conference highlighted collaborative efforts across academia, industry, and regulators that are enhancing blood purification systems including advancements in blood purification technologies, smart monitoring systems, and integrated care platforms.<\/p>\n<p>Companies like <span class=\"xn-location\">Chongqing&#8217;s<\/span> SWS Medical are at the forefront of this movement, exemplifying innovation and significantly contributing to national standards. Tong Jin, Director of SWS Medical&#8217;s Technology Center, shared the company&#8217;s decade-long journey, highlighting breakthroughs in dialysis machines and high-end continuous renal replacement therapy (CRRT) equipment. &#8220;Our achievements, recognized through key national programs and patents, show that Chinese firms can lead in complex medical fields,&#8221; he said, reflecting the industry&#8217;s broader push toward self innovation and excellence.<\/p>\n<p>The conference explored innovations including precision medicine with targeted plasma purification and AI-optimized parameters, alongside breakthroughs like\u00a0ultra-pure dialysis via Central Concentrate Delivery System and IoT-enabled smart peritoneal dialysis management. Advances in\u00a0treatments for kidney diseases, including Immunoglobulin A nephropathy and emerging technologies like gene sequencing and stem cells, signal a shift toward proactive health management. These multidisciplinary and early intervention efforts have significant global potential.<\/p>\n<p>The conference centered on integrating\u00a0artificial intelligence to develop &#8220;Smart Hemodialysis&#8221; ecosystems, with\u00a0companies like SWS Medical leading this shift through\u00a0their &#8220;Device + System + Service&#8221; model that synergies medical devices, data analytics, and remote services to boost efficiency and expand accessibility, especially in underserved \u00a0areas. With domestic medical device registration reaching \u00a067.01% and over 90% of blood perfusion devices now localized, <span class=\"xn-location\">China&#8217;s<\/span> advancements\u00a0are\u00a0firmly supported by robust government initiatives and market-driven innovation, ensuring adherence to stringent clinical and regulatory standards.<\/p>\n<p>Chinese companies are now exporting affordable, high-quality solutions that challenge\u00a0Western-dominated markets while aligning with the &#8220;Healthy China 2030&#8221; strategy and the World Health Organization&#8217;s 2030 goals for chronic kidney disease. As <span class=\"xn-location\">China<\/span> approaches \u00a0the conclusion\u00a0of its 14th Five-Year Plan, this\u00a0conference signifies a pivotal moment, with the committee&#8217;s leadership and companies\u00a0like SWS Medical spearheading a transformation\u00a0toward intelligent, patient-centered, and globally competitive technologies.<\/p>\n<p>For patients, this\u00a0translates to\u00a0greater access to life-saving treatments, while for the global medical community, it underscores <span class=\"xn-location\">China&#8217;s<\/span> emergence as a leader in healthcare innovation. As Professor Wang eloquently stated, &#8220;The spark of innovation ignited here will transform lives far beyond <span class=\"xn-location\">China&#8217;s<\/span> borders.&#8221;<\/p>\n<p>\u00a0<\/p>\n<p><!-- \/wp:html --><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[5,7],"tags":[],"class_list":["post-21709","post","type-post","status-publish","format-standard","hentry","category-cision-pr-newswire","category-cision-pr-newswire-en"],"_links":{"self":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/21709","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21709"}],"version-history":[{"count":0,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/21709\/revisions"}],"wp:attachment":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21709"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21709"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21709"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}